Breaking News
11 hours ago
Simantini Singh Deo

Siegfried adds 100 m³ reactor capacity at its German site, expanding European small-molecule API output for CDMO clients.
Simantini Singh Deo

Norwich Pharmaceuticals gains FDA approval for the first generic baloxavir marboxil, cleared ahead of the 2026–2027 influenza season.
Simantini Singh Deo

FDA's June 2026 TECARTUS approval and 2025 REMS elimination reshape post-market obligations for Kite's CAR-T program.
Simantini Singh Deo

Novartis gains FDA approval for ITVISMA in SMA patients aged 2 and older, expanding the label and raising GMP compliance considerations for ATMP manufacturers.
Simantini Singh Deo
